USE OF AN ALGOSTERONE RECEIVER ANTAGONIST TO IMPROVE COGNOSCITIVE FUNCTION.

摘要

Use of eplerenone or pharmaceutically acceptable salts thereof in the preparation of a medicament for the treatment of a cognitive dysfunction selected from the group consisting of psychosis, cognitive disorder characterized by one or more symptoms selected from the group consisting of confusion, disorientation, disturbance of the memory and behavioral disorganization, mood disorder characterized by one or more symptoms selected from the group consisting of bipolar disorder, persistent abnormality of mood, altered activity rhythm, altered sleep and altered appetite, anxiety disorder characterized by one or more symptoms selected from the group consisting of panic, dysphoria, obsession, irrational fear, ritualistic behavior, compulsion and image behavior, and personality disorder in a subject suffering from one or more states selected from the group of states consisting of heart disease, kidney disease, em Bolia and vascular disease.